ACCESSWIRE
01 Jun 2023, 18:05 GMT+10
Company plans Early Feasibility Study in the US for late 2023
PARIS, FRANCE / ACCESSWIRE / June 1, 2023 / Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive device for treating certain heart failure patients with associated pulmonary hypertension, announced today the successful first patient enrollment in its first-in-human clinical study.
The procedure was performed at the Israeli-Georgian Medical Center Helsicore in Tbilisi, Georgia, by Dr. Irakli Gogorishvili, Head of Interventional Cardiology at Helsicore and Dr. Alex Rothman, Senior Clinical Research Fellow at the University of Sheffield in the United Kingdom.
'Gradient has made significant progress over the past few years over the past few years,' said Dr. Rothman. 'With no approved drug or device therapies for this group of pulmonary hypertension patients, the technology is poised to have a huge impact on patient care.'
'My team at Helsicore is happy to be working with Gradient to bring this therapy to patients for the first time in the world at our center,' said Dr. Gogorishvili. 'We are actively screening for additional patients and look forward to working with our study collaborators to finish enrollment in this trial.'
Between a third and half of heart failure patients around the world have elevated pulmonary vascular resistance, a combination that is shown to lead to an increased risk of mortality and hospitalization. The Gradient device works to down-regulate the sympathetic nervous system's input into the pulmonary vascular tree to reduce vascular resistance and provide a treatment option for patients with this debilitating condition.
'I'm proud of the hard-working team at Gradient who have gotten us to this significant milestone,' said Martin Grasse, CEO of Gradient. 'We are one step closer to bringing this important therapy to patients. In conjunction with our first-in-human study in Georgia, we will be working with the FDA to get approval for, then initiate, an IDE Early Feasibility Study in the United States later this year.
About Gradient Denervation Technologies
Gradient Denervation Technologies has developed a minimally invasive device for the treatment of pulmonary hypertension in patients with heart failure. Gradient leverages intellectual property developed at Stanford University and has been incubated since 2020 by Sofinnova MD Start, a Paris-based medtech accelerator that actively works with clinicians and entrepreneurs to develop disruptive medical devices. The Gradient device is for investigational use only and is not approved for commercial use.
For more information:
CEO of Gradient
Martin Grasse
martin@gradientdenervation.com
www.gradientdenervation.com.
+33 01 76 23 41 00
SOURCE: Gradient Denervation Technologies
Get a daily dose of Paris Guardian news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Paris Guardian.
More InformationNEW YORK: This week, the Virginia-based Students for Fair Admissions, founded by affirmative action opponent Edward Blum, sued the U.S. ...
LONDON, U.K.: Jet engine maker CFM International said this week that thousands of engine components may have been sold with ...
BATAM, Indonesia: Due to mounting geopolitical tensions and protests against China's activities in the South China Sea, ASEAN member nations ...
FREMONT, California: This week, brain-chip startup Neuralink, owned by billionaire Tesla CEO Elon Musk, said an independent review board granted ...
BOSTON, Massachusetts: Officials said that a Delta flight from Chicago to Boston that was possibly struck by lightning landed safely ...
JAKARTA, Indonesia: An Indonesian court sentenced Lina Lutfiawati, also known as Lina Mukherjee, to two years in prison this week ...
BURBANK, California: A note by Needham media analyst Laura Martin released this week revealed that CEO Bob Iger told investors ...
TOKYO, Japan: This week, Toshiba revealed that a tender offer worth US$14 billion from Japan Industrial Partners (JIP) was a ...
HANOI, Vietnam: While the European Union (EU) is set to impose tariffs on its Chinese rivals, Vietnamese electric vehicle (EV) ...
BEIJING, China: In a country where weddings are traditionally grand and expensive events, China's wedding industry, estimated at some US$500 ...
PARIS, France: Amid the imminent launch of the iPhone 15, unions representing Apple store workers in France have called for ...
SEATTLE, Washington: To expand its next-day delivery services for shoppers, Amazon said it plans to hire 250,000 more U.S. workers ...